News

Teva news, press releases, and media contact information

Press Releases
Keyword Search
 
  
For all global news, visit our corporate site.
02/20/2018Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn® in the United StatesJERUSALEM--(BUSINESS WIRE)--Feb. 20, 2018-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive lau... 
02/12/2018Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation AerosolFirst and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath C... 
02/09/2018Teva Announces Launch of a Generic Version of Syprine® in the United StatesJERUSALEM--(BUSINESS WIRE)--Feb. 9, 2018-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of gene... 
02/08/2018Teva Reports 2017 Full Year and Fourth Quarter Financial ResultsJERUSALEM--(BUSINESS WIRE)--Feb. 8, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the year and the q... 
01/25/2018Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results at 8 a.m. ET on February 8, 2018JERUSALEM--(BUSINESS WIRE)--Jan. 25, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will issue a press ... 
01/15/2018Teva Announces U.S. FDA Approval of TRISENOX® (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic LeukemiaJERUSALEM--(BUSINESS WIRE)--Jan. 15, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that the U.S. Food and D... 
01/08/2018Teva Announces Global License Agreement with Alder BioPharmaceuticals® in the Field of Anti-CGRP-Based TherapyJERUSALEM--(BUSINESS WIRE)--Jan. 8, 2018-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced that its subsidiary... 
01/04/2018Teva to Present at the 36th Annual J.P. Morgan Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Jan. 4, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 36th A... 
01/02/2018Teva Announces Launch of an Authorized Generic of Estrace® Cream in the United StatesJERUSALEM--(BUSINESS WIRE)--Jan. 2, 2018-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of an a...